Cecile Anne Neyt
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cecile Anne Neyt.
Infection and Immunity | 2010
Merit Melin; Emmanuel Enrico Alexandre Di Paolo; Leena Tikkanen; Hanna Jarva; Cecile Anne Neyt; Helena Käyhty; Seppo Meri; Jan Poolman; Merja Väkeväinen
ABSTRACT The pneumococcal histidine triad (Pht) proteins PhtA, PhtB, PhtD, and PhtE form a group of conserved pneumococcal surface proteins. Humans produce antibodies to Pht proteins upon exposure to pneumococcus, and immunization of mice has provided protective immunity against sepsis and pneumonia and reduced nasopharyngeal colonization. Pht proteins are candidates for inclusion in multicomponent pneumococcal protein vaccines. Their biological function in pneumococcal infections is not clear, but a role in complement inhibition has been suggested. We measured complement deposition on wild-type and Pht mutant strains in four genetic backgrounds: Streptococcus pneumoniae D39 (serotype 2) and R36A (unencapsulated derivative of D39) and strains of serotypes 3, 4, and 19F. PspA and PspC single and double mutants were compared to the wild-type and Pht-deficient D39 strains. Factor H binding was measured to bacterial cells, lysates, and protein antigens. Deletion of all four Pht proteins (Pht−) resulted in increased C3 deposition on the serotype 4 strain but not on the other strains. Pht antigens did not bind factor H, and deletion of Pht proteins did not affect factor H binding by bacterial lysates. The Pht− mutant serotype 4 strain bound slightly less factor H than the wild-type strain when binding was measured by flow cytometry. Pht proteins may play a role in immune evasion, but the mechanism of function is unlikely to be mediated by factor H binding. The relative contribution of Pht proteins to the inhibition of complement deposition is likely to be affected by the presence of other pneumococcal proteins and to depend on the genetic background.
Clinical and Vaccine Immunology | 2009
Emma Holmlund; Beatriz P. Quiambao; Jukka Ollgren; Teija Jaakkola; Cecile Anne Neyt; Jan Poolman; Hanna Nohynek; Helena Käyhty
Archive | 2005
Cindy Castado; Gerald W. Fischer; Simon J. Foster; John F. Kokai-Kun; Nicolas Pierre Fernand Lecrenier; Andrew Lees; James J. Mond; Cecile Anne Neyt; Jan Poolman
Archive | 2005
Cindy GlaxoSmithKline Bio. sa Castado; Nicolas Pierre Fernand Lecrenier; Cecile Anne Neyt; Jan GlaxoSmithKline Bio. sa Poolman
Archive | 2002
Francois-Xavier Jacques Berthet; Philippe Denoel; Cecile Anne Neyt; Jan Poolman; Joelle Thonnard
Archive | 2009
Emma Holmlund; Beatriz P. Quiambao; Jukka Ollgren; Teija Jaakkola; Cecile Anne Neyt; Jan Poolman; Hanna Nohynek; Helena Käyhty
Archive | 2005
Cindy GlaxoSmithKline Bio. sa Castado; Nicolas Pierre Fernand Lecrenier; Cecile Anne Neyt; Jan GlaxoSmithKline Bio. sa Poolman
Archive | 2005
Cindy Castado; Nicolas Pierre Fernand Lecrenier; Cecile Anne Neyt; Jan Poolman
Archive | 2005
Cindy Castado; Nicolas Pierre Fernand Lecrenier; Cecile Anne Neyt; Jan Poolman
Archive | 2002
Francois-Xavier Jacques Berthet; Philippe Denoel; Cecile Anne Neyt; Jan Poolman; Joelle Thonnard